Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study
Top Cited Papers
- 9 June 2009
- journal article
- research article
- Published by Elsevier in The Lancet Oncology
- Vol. 10 (7) , 663-671
- https://doi.org/10.1016/s1470-2045(09)70154-8
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- ODC1 Is a Critical Determinant of MYCN Oncogenesis and a Therapeutic Target in NeuroblastomaCancer Research, 2008
- RTPrimerDB: the portal for real-time PCR primers and probesNucleic Acids Research, 2008
- Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma GroupBritish Journal of Cancer, 2008
- Identification of low intratumoral gene expression heterogeneity in neuroblastic tumors by genome‐wide expression analysis and game theoryCancer, 2008
- CHD5 , a Tumor Suppressor Gene Deleted From 1p36.31 in NeuroblastomasJNCI Journal of the National Cancer Institute, 2008
- CADM1 is a strong neuroblastoma candidate gene that maps within a 3.72 Mb critical region of loss on 11q23BMC Cancer, 2008
- Pathways connecting inflammation and cancerCurrent Opinion in Genetics & Development, 2008
- A gene sets approach for identifying prognostic gene signatures for outcome predictionBMC Genomics, 2008
- Prediction of clinical outcome and biological characterization of neuroblastoma by expression profilingOncogene, 2005
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002